FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13252401000001102: Co-careldopa 50mg/200mg modified-release tablets (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109780401000001112 Co-careldopa 50mg/200mg modified-release tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    109780501000001111 Co-careldopa 50mg/200mg modified-release tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Co-careldopa 50mg/200mg modified-release tablets Plays role Antiparkinson therapeutic role false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Is a Product containing carbidopa and levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has active ingredient Carbidopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has dispensed dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has specific active ingredient Carbidopa monohydrate false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has specific active ingredient Levodopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Carbidopa false Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Co-careldopa 50mg/200mg modified-release tablets 50 tablet Has VMP False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets 30 tablet Has VMP False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets 60 tablet Has VMP False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Ennogen Healthcare Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Pharma-z Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Apodespan PR 50mg/200mg tablets (Accord Healthcare Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Icarus Pharmaceuticals Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Colorama Pharmaceuticals Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Mawdsley-Brooks & Company Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (CST Pharma Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (DE Pharmaceuticals) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Niche Pharma Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (J M McGill Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (Cubic Pharmaceuticals Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Lecado 200mg/50mg modified-release tablets (Sandoz Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (Necessity Supplies Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (Mawdsley-Brooks & Company Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Co-careldopa 50mg/200mg modified-release tablets (A A H Pharmaceuticals Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (Doncaster Pharmaceuticals Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Caramet 50mg/200mg CR tablets (Teva UK Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Tilolec 200mg/50mg modified-release tablets (Tillomed Laboratories) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (PI) (Dowelhurst Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (PI) (Waymade Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier
    Sinemet CR 50mg/200mg tablets (Organon Pharma (UK) Ltd) Is a False Co-careldopa 50mg/200mg modified-release tablets Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start